United States · Business magazines · Axios Markets

Exclusive: OpenAI acquires biotech startup as AI race moves into drug development

Published by Axios Markets · United States 11 h ago

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios. Why it…

Read the full article on Axios Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.axios.com)

Also worth reading

Inc.

Why Your ChatGPT Traffic Dropped in October (And Why It Might Be a Reporting Trap)

Quartz

SpaceX reported $4.4 billion net income as revenue rose 161% to $14.6 billion

Fortune

SpaceX posts first operating profit as public company as AI revenue nearly triples to $7.6 billion—cruising past Starlink

Kiplinger

Dow Gains 529 Points on 3M Data Center Deal: Stock Market Today

Entrepreneur

The Instincts That Got You Promoted Are Now Working Against You. Here’s How to Replace Them.

Fast Company